Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Visine for Contacts** is a sterile lubricating and rewetting ophthalmic solution intended for use while wearing daily-wear and extended-wear soft hydrophilic contact lenses. The formulation contains hypromellose and glycerin in an isotonic borate-buffered solution, with potassium sorbate and edetate disodium as preservatives. It is used to moisten contact lenses, refresh and soothe the eyes, and help remove particulate matter associated with lens discomfort or transient blurring. The product was originally cleared in the United States as a soft contact-lens accessory product and was evaluated as a rewetting-drop comparator in a completed Phase 4 study in contact lens-related dry eye.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Visine for Contacts.